SmartPill Monitoring System

DEVICE2 trials

Sponsors

Medtronic - MITG, Atmo Biosciences Pty Ltd

Conditions

GastroparesisIBSSlow Transit Constipation

Unknown Phase

Clinical Management With SPM System and Validation of the SPM 5 Hour Cutoff in Patients With Symptoms of Gastroparesis

TerminatedNCT02022826

Medtronic - MITGGastroparesis

Start: 2014-01-31End: 2017-03-31Updated: 2017-11-30

Comparison of the Atmo Motility Gas Capsule System to the Reference Standard

Active, not recruitingNCT05718505

Atmo Biosciences Pty LtdGastroparesis, IBS, Slow Transit Constipation

Start: 2023-06-05End: 2024-04-30Updated: 2024-01-10

Related Papers

Impact of Constipation Therapies on Severity of Gastroparesis and Constipation Symptoms in Relation to Gastric and Colonic Transit

Neurogastroenterology & Motility2025-03-032 citations

The Assessment of Gastrointestinal Transit by the Atmo Capsule: A Comparison With the SmartPill Capsule

Clinical Gastroenterology and Hepatology2025-01-3010 citations

Benefits of Prokinetics, Gastroparesis Diet, or Neuromodulators Alone or in Combination for Symptoms of Gastroparesis.

2023-10-3012 citations

Baseline Predictors of Longitudinal Changes in Symptom Severity and Quality of Life in Patients With Suspected Gastroparesis.

2020-09-218 citations

Validation of Diagnostic and Performance Characteristics of the Wireless Motility Capsule in Patients With Suspected Gastroparesis.

2018-12-1455 citations